Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity

Journal of Obesity & Metabolic Syndrome, Journal Year: 2023, Volume and Issue: 32(2), P. 121 - 129

Published: June 30, 2023

Ji-Hee Haam, Bom Taeck Kim, Eun Mi Hyuktae Kwon, Jee-Hyun Kang, Jung Hwan Park, Kyoung-Kon Sang Youl Rhee, Yang-Hyun Ki Young Lee. J Obes Metab Syndr 2023;32:121-9. https://doi.org/10.7570/jomes23031

---

Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study

EClinicalMedicine, Journal Year: 2023, Volume and Issue: 65, P. 102292 - 102292

Published: Oct. 28, 2023

The various subcategories under the overarching term of steatotic liver disease (SLD) have been recently proposed by nomenclature consensus group and endorsed international academic societies. Our aim was to investigate association between each subtype SLD incident cardiovascular (CVD) in a nationwide Korean cohort.

Language: Английский

---

2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association

Diabetes & Metabolism Journal, Journal Year: 2023, Volume and Issue: 47(5), P. 575 - 594

Published: Sept. 26, 2023

In May 2023, the Committee of Clinical Practice Guidelines Korean Diabetes Association published revised clinical practice guidelines for adults with diabetes and prediabetes. We incorporated latest research findings through a comprehensive systematic literature review applied them in manner suitable population. These are designed all healthcare providers nationwide, including physicians, experts, certified educators who manage patients or individuals at risk developing diabetes. Based on recent changes international results epidemiological study, recommended age screening has been lowered. collaboration relevant medical societies, recently managing hypertension dyslipidemia have into this guideline. An abridgment containing practical information patient education management clinic was separately.

Language: Английский

---

Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity

Journal of Obesity & Metabolic Syndrome, Journal Year: 2023, Volume and Issue: 32(1), P. 1 - 24

Published: March 22, 2023

The goal of the 8th edition Clinical Practice Guidelines for Obesity is to help primary care physician provide safe, effective patients with obesity by offering evidence-based recommendations improve quality treatment. Committee comprised individuals multidisciplinary expertise in management. A steering board seven experts oversaw entire project. Recommendations were developed as answers key questions formulated patient/problem, intervention, comparison, outcomes (PICO) format. underwent multi-level review and cross-checking received endorsement from relevant scientific societies. This guidelines includes criteria diagnosing obesity, abdominal metabolic syndrome; evaluation its complications; weight loss goals; treatment options such diet, exercise, behavioral therapy, pharmacotherapy, bariatric surgery Korean people obesity. Compared previous guidelines, current five new topics keep up constantly evolving field obesity: diagnosis women, mental illness, maintenance after loss, use information communication technology-based interventions features has improved organization, more clearly linking PICO format references. We are confident that these will be a valuable resource all healthcare professionals they describe most well-organized

Language: Английский

---

Metabolic syndrome

Nature Reviews Disease Primers, Journal Year: 2024, Volume and Issue: 10(1)

Published: Oct. 17, 2024

Language: Английский

---

2023 Obesity Fact Sheet: Prevalence of Obesity and Abdominal Obesity in Adults, Adolescents, and Children in Korea from 2012 to 2021

Journal of Obesity & Metabolic Syndrome, Journal Year: 2024, Volume and Issue: 33(1), P. 27 - 35

Published: March 27, 2024

The 2023 Obesity Fact Sheet aims to present an updated overview of obesity prevalence across all age groups, including children and adolescents.

Language: Английский

---

Gender-Specific Prevalence and Risk Factors of Sarcopenic Obesity in the Korean Elderly Population: A Nationwide Cross-Sectional Study

International Journal of Environmental Research and Public Health, Journal Year: 2023, Volume and Issue: 20(2), P. 1140 - 1140

Published: Jan. 9, 2023

Sarcopenic obesity (SO) is characterized by the combination of sarcopenia and obesity. This study evaluates gender-specific prevalence SO examines identified risk factors in a community-dwelling elderly population aged 75-84 years. A total 813 subjects participated via Korea National Health Nutrition Examination Survey. The males females was 15.46% (95%CI: 11.36-20.70) 13.59% 10.59-17.28), respectively. clinical sex-specific for were low height, high weight, body mass index, waist circumference, skeletal muscle fasting glucose, triglycerides. smoking status, cholesterol, systolic blood pressure. These results are essential to assist healthcare professionals primary care clinicians with early detection, diagnosis, intervention potential patients acknowledging sex-based factors.

Language: Английский

---

Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database

Endocrinology and Metabolism, Journal Year: 2023, Volume and Issue: 38(1), P. 10 - 24

Published: Feb. 9, 2023

The Korean National Health Information Database (NHID) contains big data combining information obtained from the Insurance Service and health examinations. Data are provided in form of a cohort, NHID can be used to conduct longitudinal studies research on rare diseases. Moreover, cause date death by Statistics Korea. Research publications based have increased explosively field endocrine disorders. However, because were not collected for purposes, using limitations, particularly need operational definition In this review, we describe characteristics NHID, definitions diseases research, an overview recent endocrinology NHID.

Language: Английский

---

Dyslipidemia Fact Sheet in South Korea, 2022

Journal of Lipid and Atherosclerosis, Journal Year: 2023, Volume and Issue: 12(3), P. 237 - 237

Published: Jan. 1, 2023

This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by Society Lipid Atherosclerosis under name Dyslipidemia Fact Sheet 2022.We analyzed lipid profiles, age-standardized crude prevalence, hypercholesterolemia dyslipidemia, health behaviors adults aged ≥20 years, using Korea National Health Nutrition Examination Survey data between 2007 2020.In Korea, (total cholesterol ≥240 mg/dL or use a lipid-lowering drug) in 2020 was 24%, more than doubled from 2020. The treatment rate 55.2%, control 47.7%. (more one out three conditions [low-density lipoprotein-cholesterol ≥160 drug, triglycerides ≥200, high-density (men women) <40 mg/dL]) 40.2% 2016 However, it increased 48.2% when definition hypo-high-density lipoprotein-cholesterolemia women changed <50 mg/dL.Although has steadily remains low. Therefore, continuous efforts are needed manage through cooperation national healthcare system, patients, providers.

Language: Английский

---

Postbiotics against Obesity: Perception and Overview Based on Pre-Clinical and Clinical Studies

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(7), P. 6414 - 6414

Published: March 29, 2023

Overweight and obesity are significant global public health concerns that increasing in prevalence at an alarming rate. Numerous studies have demonstrated the benefits of probiotics against obesity. Postbiotics next generation include bacteria-free extracts nonviable microorganisms may be advantageous to host being increasingly preferred over regular probiotics. However, impact postbiotics on has not been thoroughly investigated. Therefore, goal this review is gather in-depth data ability combat reported potential alleviating This comprehensively discusses anti-obesity effects cellular, animal, clinical studies. exert via multiple mechanisms, with major mechanisms including increased energy expenditure, reduced adipogenesis adipocyte differentiation, suppression food intake, inhibition lipid absorption, regulation metabolism, gut dysbiosis. Future research should further strain identification, scale-up postbiotics, identification underlying well-defined could a promising dietary intervention for prevention management

Language: Английский

---